New Zealand Acts
[Index]
[Table]
[Search]
[Search this Act]
[Notes]
[Noteup]
[Previous]
[Next]
[Download]
[Help]
MEDICINES ACT 1981 - SECT 22
Procedure in respect of applications for Minister's consent
22 Procedure in respect of applications for Minister's consent
1 On receipt of an application for his consent to the distribution of a
medicine for the purposes of section 20(2) , the Minister shall— a) consider
all the particulars and information relating to the medicine submitted under
section 21 , and such other matters as appear to him to be relevant; and
b)
as far as practicable, weigh the likely therapeutic value of the medicine
against the risk (if any) of the use of the medicine injuriously affecting the
health of any person.
2 If, after complying with subsection (1), the Minister
is not satisfied that he should give his consent to the distribution of the
medicine, he shall refer the matter to the appropriate committee, which shall
consider the matter, and shall report on it to the Minister with a
recommendation as to the decision that the Minister should make.
3 On receipt
of the recommendation of the appropriate committee under subsection (2), the
Minister shall, before making his decision, if the recommendation is to refuse
consent to the distribution of the medicine, notify the applicant for consent
of the terms of the recommendation, and of the reasons for it.
4 The
applicant for consent may, within 20 working days after being notified under
subsection (3) of the recommendation of the appropriate committee, object to
the recommendation in writing to the Minister.
5 On receipt of an objection
under subsection (4), the Minister shall, before making his decision, refer
the matter to the Medicines Review Committee, which shall convene such meeting
or meetings as may be necessary for it to consider the matter, and shall
report on it to the Minister with a recommendation as to the decision that the
Minister should make.
Note: Medicines Act 1968 ss 20(3), 21 (UK)
History:
Section 22(4): amended, on 19 November 2025, by section 15 of the Medicines
Amendment Act 2025 (2025 No 66).
NZLII: Copyright Policy
| Disclaimers
| Privacy Policy
| Feedback